These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 10636768
21. Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2. Shivam P, Kumari S, Jamal F, Kumar V, Kumar M, Bimal S, Narayan S, Das VNR, Pandey K, Gupta AK, Das P, Singh SK. Cytokine; 2017 Aug; 96():54-58. PubMed ID: 28324803 [Abstract] [Full Text] [Related]
22. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. Yadav A, Amit A, Chaudhary R, Chandel AS, Mahantesh V, Suman SS, Singh SK, Dikhit MR, Ali V, Rabidas V, Pandey K, Kumar A, Das P, Bimal S. Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949 [Abstract] [Full Text] [Related]
23. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Kurtzhals JA, Hey AS, Jardim A, Kemp M, Schaefer KU, Odera EO, Christensen CB, Githure JI, Olafson RW, Theander TG. Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810 [Abstract] [Full Text] [Related]
24. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. Holaday BJ, Pompeu MM, Evans T, Braga DN, Texeira MJ, Sousa Ade Q, Sadick MD, Vasconcelos AW, Abrams JS, Pearson RD. J Infect Dis; 1993 Feb; 167(2):411-7. PubMed ID: 8421174 [Abstract] [Full Text] [Related]
25. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases. Dutta GD, Dutta GP. J Commun Dis; 1985 Feb; 17(1 Suppl):77-82. PubMed ID: 3831071 [No Abstract] [Full Text] [Related]
26. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome. Michałkiewicz J, Barth C, Chrzanowska K, Gregorek H, Syczewska M, Weemaes CM, Madaliński K, Stachowski J, D. DZIERZANOWSKA. Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755 [Abstract] [Full Text] [Related]
27. Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma. Hoover DL, Nacy CA, Meltzer MS. Cell Immunol; 1985 Sep; 94(2):500-11. PubMed ID: 3928173 [Abstract] [Full Text] [Related]
28. Antigen-reactive gamma delta T cells in human leishmaniasis. Russo DM, Armitage RJ, Barral-Netto M, Barral A, Grabstein KH, Reed SG. J Immunol; 1993 Oct 01; 151(7):3712-8. PubMed ID: 8376802 [Abstract] [Full Text] [Related]
29. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE. Bahrenscheer J, Kemp M, Kurtzhals JA, Gachihi GS, Kharazmi A, Theander TG. APMIS; 1995 Feb 01; 103(2):131-9. PubMed ID: 7748537 [Abstract] [Full Text] [Related]
30. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis. Salotra P, Raina A, Ramesh V. Trans R Soc Trop Med Hyg; 1999 Feb 01; 93(1):98-101. PubMed ID: 10492802 [Abstract] [Full Text] [Related]
31. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India. Theinert SM, Basu R, Forgber M, Roy S, Sundar S, Walden P. Infect Immun; 2005 Oct 01; 73(10):7018-21. PubMed ID: 16177384 [Abstract] [Full Text] [Related]
32. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG. Misra A, Dube A, Srivastava B, Sharma P, Srivastava JK, Katiyar JC, Naik S. Vaccine; 2001 May 14; 19(25-26):3485-92. PubMed ID: 11348715 [Abstract] [Full Text] [Related]
33. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. Stäger S, Smith DF, Kaye PM. J Immunol; 2000 Dec 15; 165(12):7064-71. PubMed ID: 11120835 [Abstract] [Full Text] [Related]
34. ELISA titres to polysaccharide antigens of Leishmania donovani promastigotes in kala-azar. Ray R, Ghose AC. Trans R Soc Trop Med Hyg; 1986 Dec 15; 80(6):998. PubMed ID: 3603654 [No Abstract] [Full Text] [Related]
35. Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis. Kaul P, Malla N, Kaur S, Mahajan RC, Ganguly NK. Trans R Soc Trop Med Hyg; 2000 Dec 15; 94(2):173-5. PubMed ID: 10897360 [Abstract] [Full Text] [Related]
36. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB, Phillips JH, Figdor CG, Lanier LL. J Immunol; 1998 Jun 01; 160(11):5239-45. PubMed ID: 9605119 [Abstract] [Full Text] [Related]
37. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby PC, Yang J, Zhao W, Perez LE, Cheng J. Infect Immun; 2001 Aug 01; 69(8):4719-25. PubMed ID: 11447143 [Abstract] [Full Text] [Related]
39. Functional and phenotypic changes in human lymphocytes after coincubation with Leishmania donovani in vitro. Hviid L, Sørensen AL, Kharazmi A, Theander TG. Infect Immun; 1990 Oct 01; 58(10):3163-7. PubMed ID: 2144843 [Abstract] [Full Text] [Related]
40. Species and stage specificity of Leishmania donovani antigens. White AC, Hanham C. J Parasitol; 1991 Feb 01; 77(1):142-50. PubMed ID: 1704058 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]